QuickSTAT, a subsidiary of Kuehne+Nagel, has opened a new control tower and conditioning facility in Singapore.
The investment is part of Kuehne+Nagel and QuickSTAT’s pharma and healthcare strategy to further expand their logistics capabilities to serve customers across Asia Pacific.
As a leading biomedical science hub in the heart of Asia and its proximity to the rest of the region, Singapore is a strategic location for the new QuickSTAT facility.
QuickSTAT is an expert in managing global clinical trial logistics for all phases of the product lifecycle from research and drug development through to commercialisation. The company specialises in time and temperature shipping of clinical research samples, biologics, investigational drugs, clinical trial supplies and vaccines in order to help bring new drugs and medical protocols to market safely and quickly.
The new conditioning facility located at Kuehne+Nagel’s regional centre of excellence – the Singapore Logistics Hub – caters to a full suite of healthcare logistics services for all stages of the pharmaceutical product lifecycle.
It provides superior management of cell and gene therapies, where QuickSTAT’s specialists will ensure proper handling, packaging and storage of the time-and-temperature sensitive products.
Additionally, the facility includes a controlled-ambient warehouse and in-transit storage for vaccines, investigational drugs, patient clinical specimens and active pharmaceutical ingredient (API)